Vismodegib in Treating Younger Patients With Recurrent or Refractory Medulloblastoma

Clinical trial NCT01239316 · COMPLETED

Trial details

NCT number: NCT01239316
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Childhood Medulloblastoma

Start date: 2010-11-01
Primary completion: 2014-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.